Estrogen control / PCT drugs

Aromasin 25 mg ( exemestane ) 30 tablets

Aromasin (chemical name: exemestane) is an aromatase inhibitor approved by the U.S. Food and Drug Administration (FDA) to treat:

• postmenopausal women diagnosed with hormone-receptor-positive, early-stage breast cancer after they’ve taken tamoxifen for 2 to 3 years to reduce the risk of the cancer coming back
• postmenopausal women diagnosed with advanced-stage or metastatic hormone-receptor-positive breast cancer

Women stop taking tamoxifen when they start taking Aromasin.

Aromatase inhibitors can’t stop the ovaries from making estrogen, so aromatase inhibitors are mainly used to treat postmenopausal women. But because aromatase inhibitors are so much more effective than tamoxifen in postmenopausal women, researchers wondered if there were a way to successfully treat premenopausal women diagnosed with hormone-receptor-positive, early-stage breast cancer with an aromatase inhibitor. Results from the SOFT (Suppression of Ovarian Function Trial) study published in 2015 suggest that premenopausal women diagnosed with hormone-receptor-positive breast cancer can be successfully treated with Aromasin if their ovarian function is suppressed. If you’re a premenopausal woman willing to take medicine to suppress your ovaries, you may be able to take Aromasin instead of tamoxifen for your hormonal therapy treatment.